Sparsentan, sold under the brand name Filspari, is a medication used for the treatment of primary immunoglobulin A nephropathy. Sparsentan is an endothelin and angiotensin II receptor antagonist
| CAS No. | 254740-64-2 |
| Molecular Weight (g/mol) | |
| Molecular Formula | 592.7 |